Drug delivery devices with drug-permeable component and methods
Drug delivery devices having a drug-permeable component and methods of making and using the same are provided. Drug delivery devices include a housing having a first and second wall structures that are adjacent one another and together form a tube defining a drug reservoir lumen. The second wall structure, or both the first wall structure and the second wall structure, are permeable to water, and the first wall structure is impermeable to the drug while the second wall structure is permeable to the drug, such that the drug is releasable in vivo by diffusion through the second wall structure.
1. A drug delivery device comprising:
an elongated, elastic housing having a drug reservoir lumen extending between a first closed end and a second closed end; and
a drug contained in the drug reservoir lumen,
wherein:
the housing comprises a tubular wall structure which comprises:
a first annular segment formed entirely of a first material which is impermeable to the drug, and
a second annular segment formed at least partially of a second material which is permeable to the drug and configured to release the drug in vivo by diffusion through the second material in the second annular segment, and
the first annular segment has a first end which is integrally formed and connected with a first end of the second annular segment.
2. The device of claim 1 , wherein the second annular segment is formed of the first material and the second material.
3. The device of claim 2 , wherein in the second annular segment, the first material forms a first arcuate portion and the second material forms a second arcuate portion, the first and second arcuate portions being integrally connected and together defining the annulus of the second annular segment.
4. The device of claim 3 , wherein the second arcuate portion has an arc angle from 15 degrees to 120 degrees.
5. The device of claim 3 , wherein the second arcuate portion has an arc angle from 30 degrees and 60 degrees.
6. The device of claim 1 , wherein the second annular segment is formed primarily of the second material.
7. The device of claim 1 , wherein the first and second annular segments are formed together in an extrusion process.
8. The device of claim 1 , wherein the tubular wall structure further comprises a third annular segment which is formed entirely of the first material and which is integrally formed and connected with an opposed second end of the second annular segment.
9. The device of claim 8 , wherein the second and third annular segments are formed together in the extrusion process.
10. The device of claim 1 , wherein the tubular wall structure has a total length (L T ) between opposed ends of the housing and the second annular segment has a length (L) which is from 5% to 50% of the total length (L T ).
11. The device of claim 1 , wherein the first material comprises silicone, thermoplastic polyurethane, or ethylene-vinyl acetate (EVA).
12. The device of claim 1 , wherein the second material comprises a hydrophilic thermoplastic polyurethane.
13. The device of claim 1 , wherein the device is configured to be elastically deformable from a coiled retention shape suited to retain the device within the urinary bladder of a patient to an uncoiled shape suited for insertion through the patient's urethra and into the bladder, in the absence of a wire retention frame.
14. The device of claim 1 , wherein the drug is in the form of a plurality of solid tablets.
15. A drug delivery device comprising:
a tubular housing having a closed drug reservoir lumen bounded by a wall structure comprising at least one thermoplastic material; and
a drug contained in the drug reservoir lumen,
wherein:
at least a portion of the wall structure is water permeable,
at least a portion of the wall structure is permeable to the drug such that the drug is releasable in vivo by diffusion through the drug permeable portion of the wall structure,
the tubular housing is thermally shape set to have a coiled retention shape suited to retain the device within the urinary bladder of a patient and is elastically deformable from the coiled retention shape to an uncoiled shape suited for insertion of the device through the patient's urethra and into the bladder, and
the wall structure comprises: (i) a first annular segment formed entirely of a first material which is impermeable to the drug, and (ii) a second annular segment formed at least partially of a second material which is permeable to the drug and configured to release the drug in vivo by diffusion through the second material in the second annular segment, wherein the first annular segment has a first end which is integrally formed and connected with a first end of the second annular segment.
16. The device of claim 15 , wherein the first material comprises a first thermoplastic polyurethane composition and the second material comprises a second thermoplastic polyurethane composition which is different from the first thermoplastic polyurethane composition.
17. The device of claim 15 , wherein the first and second wall structures are integrally formed in a coextrusion process.
18. The device of claim 15 , wherein the coiled retention shape comprises at least one loop having a radius of curvature of at least 0.5 cm.
19. The device of claim 15 , wherein the drug is in the form of a plurality of solid tablets.
20. A method of administering a drug to a patient in need thereof, comprising:
inserting into the patient the device of claim 1 ;
permitting water to be imbibed through the tubular wall structure to solubilize the drug; and
permitting the solubilized drug to be released from the device by diffusion through the second annular segment of the tubular wall structure.